Accentia Biopharmaceuticals, Inc. · Tampa, FL United States ·(Pink Sheets: ABPIQ)
Company Description
Phone: 813-864-2554
Fax: 813-258-6912
View Accentia Biopharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Accentia Biopharmaceuticals emphasizes runny noses. The company acquires and develops treatments for respiratory conditions, as well as other ailments. Its development-stage drugs include sinus inflammation treatment SinuNase, multiple sclerosis drug Revimmune, and BiovaxID, a possible vaccine for non-Hodgkin's lymphoma being developed by majority-owned subsidiary Biovest International . Accentia also develops cell production instruments, including the AutovaxID system, and offers pharmaceutical consulting services. The company and its subsidiaries (including Biovest) filed for Chapter 11 bankruptcy protection in late 2008. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Accentia Biopharmaceuticals, Inc. Financials
| Company Type | Public - Pink Sheets: ABPIQ Headquarters |
| Fiscal Year-End | September |
| 2007 Sales (mil.) | $18.3 |
| 2007 Employees | 140 |
Accentia Biopharmaceuticals, Inc. Executives
16 executives listed for Accentia Biopharmaceuticals, Inc.'s Tampa, FL location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Francis O'Donnell | Network |
| President, General Counsel, and Director | Samuel Duffey | Network |
| CFO and Director | Alan Pearce | Network |
Competition
Competitive Landscape for Accentia Biopharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Accentia Biopharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!